Cladribine for Multiple Sclerosis
Links shared publicly online about this topic
FDA Extends Review of Cladribine for MS - Pathophilia
bmartinmd.com — “FDA Extends Review of Cladribine for MS - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on November 29, 2010 at 4:30 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
FDA Extends Review of Cladribine for MS: Merck Serono's not out the race to market an oral pill for multiple scl... http://bit.ly/igbV67
FDA Rejects Oral Cladribine for MS - Pathophilia
bmartinmd.com — “FDA Rejects Oral Cladribine for MS - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on March 2, 2011 at 6:48 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
FDA Rejects Oral Cladribine for MS: Delivering a minor shock, the FDA issued a complete response letter to Merck... http://bit.ly/ePfRhV
FDA Rejects Oral Cladribine for Multiple Sclerosis - QualityPoint Technologies
qualitypointtech.net — “Drug maker Merck Serono announced today it received a complete response letter from US regulators. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on March 2, 2011 at 7:35 pm By:
FDA Rejects Oral Cladribine for Multiple Sclerosis: Drug maker Merck Serono announced today it received a complete... http://bit.ly/grLwa9
Medical News: FDA Turns Down Cladribine for MS - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “The FDA said it won't approve the oral multiple sclerosis drug cladribine without more data on its safety and benefit-risk balance.” View full resource at medpagetoday.com
Most Recently Shared on March 2, 2011 at 3:05 pm By:
FDA Turns Down Cladribine for MS http://bit.ly/ik9fGR
Merck Serono to Appeal Negative CHMP Opinion on Cladribine in MS - QualityPoint Technologies
qualitypointtech.net — “The company has notified the European Medicines Agency it intends to appeal the decision that derailed hopes for European approval of the oral treatment for multiple sclerosis. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 9:36 pm By:
Merck Serono to Appeal Negative CHMP Opinion on Cladribine in MS: The company has notified the European Medicines ... http://bit.ly/bvxVFb
Company Decides Not to Seek Approval of Cladribine for MS : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on June 22, 2011 at 5:40 pm By:
News! Company Decides Not to Seek Approval of Cladribine for MS http://bit.ly/m7mqJC
Company Decides Not to Seek Approval of Cladribine for MS : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on June 22, 2011 at 8:12 pm By:
Merck Serono decides not to seek approval of Cladribine for #MS. http://t.co/vZ14GzE
Medical News: Merck KGaA Throws in Towel on Cladribine for MS - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “Facing skepticism from U.S. and European regulators, Merck KGaA has given up efforts to gain approval for the oral immunosuppressant drug cladribine for multiple sclerosis, the company announced.” View full resource at medpagetoday.com
Most Recently Shared on June 22, 2011 at 6:32 pm By:
Merck KGaA Throws in Towel on Cladribine for MS http://bit.ly/lY6tkv
FDA Sends Letter Stating that the Application to Market Oral Cladribine for MS is Not Ready for Approval -- Outlines Need for Additional Data : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on March 2, 2011 at 10:53 pm By:
#FDA sends letter stating that the application to market oral cladribine for #MS is not ready for approval: http://bit.ly/cladribine
FDA Sends Letter Stating that the Application to Market Oral Cladribine for MS is Not Ready for Approval -- Outlines Need for Additional Data : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on March 2, 2011 at 3:22 pm By:
News! FDA Sends Letter Stating that the Application to Market Oral Cladribine for MS is Not Ready for Approval -... http://bit.ly/f0zXG3
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
medicalnewstoday.com — “Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tabl” View full resource at medicalnewstoday.com
Most Recently Shared on September 5, 2010 at 11:56 am By:
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia: Merck KGaA announced that the Australian ... http://mnt.to/f/3JkB
Neurology Medical News about Multiple Sclerosis Cladribine
mdlinx.com — “A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis” View full resource at mdlinx.com
Most Recently Shared on February 5, 2010 at 1:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro:A Placebo-Controlled Trial of Oral #Cladribine for Relapsing Multiple Sclerosishttp://bit.ly/aUCGAQ
Cladribine Tablets For Relapsing Multiple Sclerosis, FDA Extends Priority Review
medicalnewstoday.com — “The Food and Drug Administration (FDA) has extended the review period for Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis by another three months, to give time for a” View full resource at medicalnewstoday.com
Most Recently Shared on November 26, 2010 at 6:09 pm By:
Cladribine Tablets For Relapsing Multiple Sclerosis, FDA Extends Priority Review The Food and Drug Administration (FDA).. http://dld.bz/8jnB
Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis
disabled-world.com — “EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis” View full resource at disabled-world.com
Most Recently Shared on November 26, 2010 at 6:03 pm By:
Disabled World Health Advocate and Health News
Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis http://ff.im/-uoaoJ
FDA extends review period of Cladribine Tablets for MS therapy
news-medical.net — “EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.” View full resource at news-medical.net
Most Recently Shared on November 26, 2010 at 8:49 am By:
News-Medical.Net Health News and Oncology
Oncology News: FDA extends review period of Cladribine Tablets for MS therapy: EMD Serono, an affiliate of Merck... http://bit.ly/dXkQQg
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Barbara J. Martin
Neurologist emeritus, Pathophilia blogger, noir lover
-
Barbara J. Martin
Neurologist emeritus, Pathophilia blogger, noir lover
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement
